European Centre for Environment and Human Health, University of Exeter, Knowledge Spa, Royal Cornwall Hospital, Truro TR1 3HD, UK; School of Geography, Earth and Environmental Sciences, University of Plymouth, Drake Circus, Plymouth PL4 8AA, UK.
School of Natural Sciences, Bangor University, Deiniol Road, Bangor LL57 2UW, UK; Centre for Environmental and Climate Science/Aquatic Ecology, Department of Biology, Lund University, 223 62 Lund, Sweden.
Curr Biol. 2021 May 10;31(9):1995-2003.e4. doi: 10.1016/j.cub.2021.02.019. Epub 2021 Mar 11.
Grass (Poaceae) pollen is the most important outdoor aeroallergen, exacerbating a range of respiratory conditions, including allergic asthma and rhinitis ("hay fever"). Understanding the relationships between respiratory diseases and airborne grass pollen with a view to improving forecasting has broad public health and socioeconomic relevance. It is estimated that there are over 400 million people with allergic rhinitis and over 300 million with asthma, globally, often comorbidly. In the UK, allergic asthma has an annual cost of around US$ 2.8 billion (2017). The relative contributions of the >11,000 (worldwide) grass species (C. Osborne et al., 2011, Botany Conference, abstract) to respiratory health have been unresolved, as grass pollen cannot be readily discriminated using standard microscopy. Instead, here we used novel environmental DNA (eDNA) sampling and qPCR to measure the relative abundances of airborne pollen from common grass species during two grass pollen seasons (2016 and 2017) across the UK. We quantitatively demonstrate discrete spatiotemporal patterns in airborne grass pollen assemblages. Using a series of generalized additive models (GAMs), we explore the relationship between the incidences of airborne pollen and severe asthma exacerbations (sub-weekly) and prescribing rates of drugs for respiratory allergies (monthly). Our results indicate that a subset of grass species may have disproportionate influence on these population-scale respiratory health responses during peak grass pollen concentrations. The work demonstrates the need for sensitive and detailed biomonitoring of harmful aeroallergens in order to investigate and mitigate their impacts on human health.
草(禾本科)花粉是最重要的室外空气过敏原,可加重一系列呼吸道疾病,包括过敏性哮喘和鼻炎(“花粉热”)。了解呼吸道疾病与空气中草花粉之间的关系,以期改善预测,这具有广泛的公共卫生和社会经济意义。据估计,全球有超过 4 亿人患有过敏性鼻炎,超过 3 亿人患有哮喘,而且往往同时患有这两种疾病。在英国,过敏性哮喘每年的花费约为 28 亿美元(2017 年)。由于使用标准显微镜无法轻易区分草花粉,因此,全世界超过 11000 种(C. Osborne 等人,2011 年,植物学会议,摘要)草种对呼吸道健康的相对贡献仍未得到解决。相反,我们在这里使用了新型环境 DNA(eDNA)采样和 qPCR 技术,在 2016 年和 2017 年两个草花粉季节,测量了英国各地空气中常见草种花粉的相对丰度。我们定量证明了空气中草花粉组合具有离散的时空模式。使用一系列广义加性模型(GAMs),我们探讨了空气中花粉的发生率与严重哮喘加重(每周不到一次)以及呼吸道过敏药物(每月)的开具率之间的关系。我们的研究结果表明,在草花粉浓度高峰期,一些草种可能对这些人群规模的呼吸道健康反应产生不成比例的影响。这项工作表明,需要对有害空气过敏原进行敏感和详细的生物监测,以研究和减轻其对人类健康的影响。